Oral semaglutide is available to prescribe again and is now effectively the only GLP-1 receptor agonist available. So, this is an opportune time for ABCD members to contribute to the ABCD oral semaglutide audit. As with all our audits, all contributors will be acknowledged in publications emanating from the audit and the biggest contributors will become co-authors.
ABCD welcomes the appointment of Dr Clare Hambling as the new National Clinical Director for Diabetes and Obesity.
Professor Ketan Dhatariya (who is a fellow Norfolk resident) said:
“We are delighted that NHSE has chosen a primary care colleague to lead the development of diabetes services across England. I, and many other ABCD members, have worked with Clare in the past and of course, we have worked closely with NHSE and the previous NCDs over many years. As such we look forward to having a very fruitful collaborative partnership with Clare going forward.”
Submissions are invited from ABCD members for this named lecture at the forthcoming ABCD Conference in September 2024 which I hope you will attend.
This is the NEW tool for individuals commencing closed-loop outside of the NHS England pilot. This could be in connection with the new NICE Technology Appraisals or individuals using closed-loop already for previous indications. For individuals wishing to submit follow-up data for the NHS England Pilot please follow this link: Click here
In the fourth of the 2023 ABCD webinar series, please join Dr Debbie Wake and Dr Chris Sainsbury to discuss diabetes and artificial intelligence.
Presented by Dr Tomás Griffin
Presented by Dr Tomás Griffin
Presented by Dr Tomás Griffin
Presented by Dr Alistair Lumb
